Digitally created image of a double helix

Genetic Repositories Australia (GRA)

FACILITY INFORMATION

In accordance with NHMRC Enabling Grant requirements GRA has established 3 committees:

  • Management Committee
  • Scientific Advisory Committee
  • Independent Appeals Committee

The Management Committee (MC) operates under defined terms of reference and provides management and oversight of the day-to-day management of the GRA facility. The MC role is to ensure that appropriate ethical standards are met, ensuring open access to all researchers, and overseeing the resolution of any disputes consistent with NHMRC Enabling Facility Access Policy.

  • The GRA MC comprises the four Chief Investigators and the Facility Manager.
  • Professor Peter Schofield BScAgr, PhD, DSc
  • Executive Director & CEO, Neuroscience Research Australia
  • Assoc Prof Juleen Cavanaugh BSc, MS, PhD
  • Senior Lecturer, Australian National University
  • Dr Susan Forrest BSc (Hons), D Phil, BA Business
  • Director, Australian Genome Research Facility Ltd
  • Professor John Hopper BA, MSc, PhD
  • NHMRC Senior Principal Research Fellow, The University of Melbourne
  • Steve Turner BAppSc, BSc (Hons), MSc, Grad Cert Man
  • Facility Manager, Genetic Repositories Australia.

A Scientific Advisory Committee (SAC) which consists of nine members. The SAC membership reflects a skills-based committee, with an appropriate mix of expertise to allow the SAC to provide advice in all areas of operations of the GRA facility. GRA’s SAC provides strategic advice and reviews progress towards establishing and operating GRA as an NHMRC Enabling Facility, including advice on governance, management and operations. The SAC is comprised of a majority of external appointments & includes all members from the GRA MC and the Facility Manager (Ex Officio).

External SAC members are listed below:

  • Professor Graham MacDonald, Formerly External Licensing Coordinator, Merck Sharp & Dohme (Australia)
  • Professor Don Chalmers, Faculty of Law, University of Tasmania
  • Theo Magoulas, Assistant University Solicitor, University of Technology Legal Services
  • Professor Phil Mitchell, Head School of Psychiatry, University of NSW
  • Dr Bruce Ross, Health Solutions Executive, Health Solutions Group Microsoft Australia.

An Independent Appeals Committee (IAC) of ’eminent persons’ who are independent of GRA and represent a range of consumer, scientific and social scientific disciplines. The IAC has been established to resolve any dispute concerning access to or operations of the facility and comprises individuals outside both Management and the SAC. The IAC comprises the following members:

  • Professor Ron Trent, Professor of Medicine at University of Sydney and Royal Prince Alfred Hospital
  • Peter Kemp, Founder of Kemp Strang Lawyers
  • A Consumer or Community Representative, (Position currently vacant)
See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

The cold case of schizophrenia - broken wide open!

‘It is like they were miraculously healed!’’ Schizophrenia is diagnosed by clinical observation of behaviour and speech. This is why NeuRA researchers are working hard to understand the biological basis of the illness. Through hours of work and in collaboration with doctors and scientists here and around the world, NeuRA has made an amazing breakthrough. For the first time, researchers have discovered the presence of antibodies in the brains of people who lived with schizophrenia. Having found these antibodies, it has led NeuRA researchers to ask two questions. What are they doing there? What should we do about the antibodies– help or remove them? This is a key breakthrough. Imagine if we are treating schizophrenia all wrong! It is early days, but can you imagine the treatment implications if we’ve identified a new biological basis for the disease? It could completely change the way schizophrenia is managed, creating new treatments that will protect the brain. More than this, could we be on the verge of discovering a ‘curable’ form of schizophrenia? How you can help We are so grateful for your loyal support of schizophrenia research in Australia, and today I ask if you will consider a gift today. Or, to provide greater confidence, consider becoming a Discovery Partner by making a monthly commitment. We believe there is great potential to explore these findings. Will you help move today’s breakthrough into tomorrow’s cure? To read more about this breakthrough, click ‘read the full story’ below. You are also invited to read ‘Beth’s story’, whose sweet son Marcus lived with schizophrenia, by clicking here.
APPEAL